1 / 30

Complexity of Signaling Networks

Complexity of Signaling Networks. Old Protein, New Tricks. Biplab Bose. Diphtheria Toxin. Exotoxin of Corynebacterium diphtheriae. Diphtheria Toxin in Therapeutics. Diphtheria Toxin in Cancer Therapeutics. HB-EGF: DT Receptor.

Download Presentation

Complexity of Signaling Networks

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Complexity of Signaling Networks Old Protein, New Tricks Biplab Bose

  2. Diphtheria Toxin Exotoxin of Corynebacterium diphtheriae.

  3. Diphtheria Toxin in Therapeutics

  4. Diphtheria Toxin in Cancer Therapeutics

  5. HB-EGF: DT Receptor Heparin-binding epidermal growth factor (EGF)-like growth factor Soluble & Membrane bound • In Oncogenesis: • Increases proliferation • Induction of migration and invasion • Promotion of angiogenesis • Normal Function • Cell proliferation • Developmental process • Wound-healing Overexpressed in tumors: Pancreatic, Liver , Gastric and Glioma

  6. HB-EGF Signaling

  7. Receptor Binding Domain of DT (RDT) R-domain of Diphtheria Toxin Diphtheria Toxin PDB ID: 1F0L

  8. Cloning of RDT SOURCE: Full Length DT cloned in pET-22b

  9. Expression & Purification of RDT • E. coli BL21(DE3) • Induction at 28 0C ,1 mM IPTG. • Purification by His-Trap Column. Western Blot using anti-His Ab SDS-PAGE of purified RDT

  10. RDT binds to HB-EGF Solid Phase ELISA: • HB-EGF Coated on 96-well ELISA plate. • Detection: anti-His Ab followed by anti-mouse Ab

  11. RDT Binds to Cell Surface HB-EGF Immunofluorescence: • Cell line: U-87 MG. • Detection: anti-His Ab followed by FITC-Conjugated anti-mouse Ab

  12. Binding Affinity of RDT SPR, Biacore X-100 • Single cycle Kinetics. • CM5 Chip, HB-EGF immobilized

  13. Can a Drug Bind to RDT ? • blue = hydrophilic and • orange red = hydrophobic.

  14. Curcumin: a Potential Therapeutic Agent

  15. Water quenches curcumin fluorescence. Curcumin: a Good Probe Fluorescence of Curcumin depends upon environment

  16. Curcumin: a Good Probe Curcumin binds to some proteins Protein binding increases fluorescence of Curcumin

  17. Docking of Curcumin on RDT Docking server: SwissDock Docking Criteria: Blind, no flexibility for RDT. RDT Structure of Curcumin (from ZINC) Source: R-domain of B-chain of 1FOL

  18. Docking of Curcumin on RDT A potential binding pose Surface Diagram Ribbon Diagram • Blue = Hydrophilic • Orange red = Hydrophobic.

  19. Docking of Curcumin on RDT Important interactions between RDT and curcumin:

  20. Curcumin Binds to RDT Fluorescence spectroscopy: • Curcumin (10 µM) in PBS, Molar ratio of Curcumin:Protein (10:1) • Incubation at 4 0C, 2 hr • Excitation at 430 nm.

  21. Curcumin Binds to RDT Fluorescence spectroscopy: • Curcumin (10 µM) in PBS, with RDT varied (0 to 2 µM) • Incubation at 4 0C, 2 hr • Excitation at 430 nm.

  22. Curcumin Binds to RDT Time-resolved fluorescence spectroscopy: • Excitation at 405 nm • Curcumin (10 µM) in PBS, Molar ratio of Curcumin:Protein(10:1) • Decay measured in ns/channel. • Exponential component analysis.

  23. Curcumin-RDT enhances accumulation of curcumin Cell Line: U-87 MG Curcumin (2 µM); molar ratio curcumin:protein (10:1) 20X

  24. Curcumin-RDT increases cellular uptake of curcumin HPLC: • Cell Line : U-87 MG • Curcumin:1 µM; • Curcumin-protein • (molar ratio:10:1) • Incubation at • 37 0C, 2 hr, Serum. • C18 column; • methanolic cell extract ** * * * No significant difference between these two (p = 0.143); **significantly different from others (p < 0.001). One-way ANOVA with pairwise comparison

  25. Curcumin-RDT potentiate curcumin MTT assay: • Cell line: U-87 MG • RDT: 0.1 µM • Incubation at 37 0C, • 72 hr, Serum-Free Significant difference between Curcumin and Curcumin-RDT: 2-way ANOVA, p<0.001

  26. Effect of Curcumin-RDT is not synergistic MTT Assay • Cell line: U-87 MG • RDT: 0.1µM; Curcumin:20 µM; • Curcumin-RDT: 20 µM:0.1 µM; ** Significantly different from other treatment groups (p < 0.001)

  27. Effect of Curcumin-RDT on cell cycle Flowcytometry • Cell line: U-87 MG • RDT: 0.1 µM; Curcumin:20 µM; • Curcumin-RDT: 20 µM:0.1 µM; • 48 hr.

  28. Curcumin-RDT enhances apoptosis Flowcytometry • Cell line: U-87 MG • RDT: 0.1 µM; Curcumin:20 µM; • Curcumin-RDT: 20 µM:0.1 µM; • Incubation at 37 0C, 48 hr. PI Annexin V

  29. Using RDT to enhance drug delivery

More Related